| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |